METTL14 and gastric cancer: m6A was found to modulate mTOR and PI3K-AKT signaling pathway in many cancer cells, and the hypermethylation-mediated via METTL14 deactivated the PI3K-AKT and mTOR signaling and suppressed gastric cancer cell proliferation and aggression [46].